Madison Small Cap Fund Increased Medpace Holdings (MEDP), Downplaying AI Fears

Madison Small Cap Fund Increased Medpace Holdings (MEDP), Downplaying AI Fears Soumya Eswaran Fri, June 12, 2026 at 10:24 PM GMT+7 3 min read ^RUT MEDP Madison Small Cap Fund, managed by Madison Funds, released its Q1 2026 investor letter. A copy of the letter is available to download here. The Madison Small Cap Fund (class I) increased by 0.10% in the first quarter, trailing behind the Russell 2000 Index (up 0.89%) and the Russell 2500 Index (up 2.04%). Despite slightly underperforming the benchmark in the quarter, core positions and IT investments showed solid performance. From a style perspective, value stocks outperformed growth, with the Russell 2000 Value Index rising ~4.5% and the Russell 2000 Growth Index falling almost 3%. The outperformance of the value is driven by weakness in speculative names aligning with the Fund’s style and preference for quality, profitable franchises. The Fund believes the market volatility, influenced by AI concerns and geopolitical tensions, presents a potential opportunity for patient investors. Please review the Fund’s top five holdings to gain insights into their key selections for 2026.

In its first-quarter 2026 investor letter, Madison Small Cap Fund Strategy highlighted Medpace Holdings, Inc. (NASDAQ:MEDP). Medpace Holdings, Inc. (NASDAQ:MEDP) is a clinical research-based drug and medical device development services provider. The one-month return of Medpace Holdings, Inc. (NASDAQ:MEDP) was 14.40%, and its shares gained 59.29% of their value over the last 52 weeks. On June 11, 2026, Medpace Holdings, Inc. (NASDAQ:MEDP) stock closed at $475.07 per share, with a market capitalization of about $13.57 billion.

Madison Small Cap Fund stated the following regarding Medpace Holdings, Inc. (NASDAQ:MEDP) in its Q1 2026 investor letter: